advertisement
 

  Back to Press Releases OneTouch Ping Glucose Management System Cleared by FDA
  Media Contact: Melissa Katz
Corporate Communications
Phone: 484.356.1844
Mobile: 215.514.0957

OneTouch® PingTM Glucose Management System Cleared by FDA
Animas Announces Clearance of Uniquely Integrated Meter/
Pump System with Remote Insulin Delivery Capabilities and Compatible Software

Photo

Photo
WEST CHESTER, PA, July 1, 2008 ľ Animas Corporation announced today the clearance of its OneTouch« PingTM Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. "People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch« Ultra« Test Strips.

OneTouch Ping also offers the following:

ezManager« MAX Diabetes Management Software
The OneTouch Ping system will also work with the recently cleared ezManager« MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager« MAX software is MAC and PC compatible.

OneTouch Ping will be available for shipment in mid-August 2008. Customers can order at any time by calling 1-877-937-7867 or visit www.animascorp.com

About Animas Corporation
As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, Inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products, visit www.animascorp.com.

About LifeScan, Inc.
LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products in the U.S., is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers. Every day, more than 4.5 million people with diabetes rely on OneTouch« Brand Products to provide accurate glucose results and help them use this information to take action so they can stay healthy.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit www.LifeScan.com.

###



                 
  Home Return to Top

Last Updated: Wednesday November 05, 2014 21:27:34
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.